The role of molecular genetics in the pathogenesis and diagnosis of neonatal sepsis.

Polymorphisms within genes encoding endogenous mediators of inflammation are good candidates for the individual differences in systemic inflammatory responses of neonates to infection. Ina similar manner, polymorphisms in the genes encoding drug metabolizing enzymes, drug transporters, and drug receptors can influence a neonate's risk of an adverse drug reaction or can alter the efficacy of drug treatment. Additionally, molecular tools are proving valuable in the diagnosis of neonatal infection. This article gives an overview of the genetic susceptibility to sepsis, discusses the use of molecular genetics in diagnostic tests for infection, and reviews the potential for more effective and specific therapies for sepsis based on genetic variability.
AuthorsAntonio Del Vecchio, Nicola Laforgia, Mario Capasso, Achille Iolascon, Giuseppe Latini
JournalClinics in perinatology (Clin Perinatol) Vol. 31 Issue 1 Pg. 53-67 (Mar 2004) ISSN: 0095-5108 [Print] United States
PMID15183656 (Publication Type: Journal Article, Review)
  • Genetic Predisposition to Disease
  • Humans
  • Infant, Newborn
  • Infection (genetics)
  • Inflammation (genetics)
  • Molecular Biology (methods)
  • Pharmacogenetics
  • Polymorphism, Genetic
  • Sepsis (diagnosis, drug therapy, etiology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: